查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1407323

宏基因体定序市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品和服务、工作流程、技术、配销通路、地区和竞争细分

Metagenomics Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Service, By Workflow, By Technology, By Distribution Channel, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球宏基因组定序市场价值为 19.6 亿美元，预计到 2028 年，预测期内将出现令人印象深刻的成长，复合CAGR为14.23%。宏基因组定序是一项革命性的科学技术，涉及对直接从环境中收集的遗传物质进行分析。样品，绕过了对个体生物体分离的需要。该方法提供了各种栖息地（包括土壤、水和人体）中微生物群落遗传多样性的整体视图。这个过程首先从混合样本中提取 DNA 或 RNA，捕获所有存在微生物的遗传物质。然后，高通量定序技术（例如次世代定序）从这些样本中产生大量遗传资料。随后使用生物资讯学工具来分析和解释资料，揭示微生物群落的身份和功能。宏基因组定序改变了我们对微生物生态系的理解，揭示了新的物种、基因和代谢途径。其应用涵盖环境科学、农业、医学和生物技术等多个领域。该技术在研究人类微生物组方面特别有影响力，有助于识别微生物对健康和疾病的贡献。宏基因组定序继续推动发现，为探索复杂环境中微生物群落的遗传丰富性和功能潜力提供了强大的工具。

宏基因组定序是一种尖端方法，透过直接分析从不同环境样本中获得的遗传物质，彻底改变了微生物群落的研究。与专注于孤立生物的传统基因组学不同，宏基因组学允许科学家研究整个微生物生态系统的集体遗传讯息。这种方法对于揭示从土壤、水到人体等各种环境中微生物的巨大多样性和功能能力至关重要。这个过程始于从含有微生物混合物的样本中提取 DNA 或 RNA。这种遗传物质代表整个微生物群落的集体基因组，然后接受高通量定序技术的处理。例如，下一代定序平台可以快速且经济高效地产生大量序列资料。生物资讯工具对于管理和解释大量遗传资料至关重要，使研究人员能够识别存在的生物体并了解它们在生态系统中的功能作用。宏基因体定序对多个学科具有变革性影响。在环境科学中，它有助于了解微生物对生物地球化学循环和生态系统动态的贡献。在农业方面，它支持土壤健康评估和永续实践的发展。在医学领域，特别是在研究人类微生物组时，宏基因组定序有助于深入了解微生物在健康和疾病中的作用。此外，该技术在生物技术中也有应用，能够发现具有工业相关性的新型酵素和代谢途径。

主要市场驱动因素

市场概况
预测期 2024-2028
2022 年市场规模 19.6亿美元
2028 年市场规模 43.3亿美元
2023-2028 年CAGR 14.23%
成长最快的细分市场 亚太地区
最大的市场 北美洲

不断提高的意识和研究计划

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和次要类型
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战与趋势概述

第 4 章：客户之声

第 5 章：全球宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品和服务（试剂和耗材、仪器、定序服务、分析和数据解释解决方案）
    • 依工作流程（样品处理和文库製备、定序、研究和生物技术）
    • 依技术分类（16s RNA 定序、鸟枪法宏基因体定序、全基因组定序与从头组装、元转录组学）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按地区

第 6 章：北美宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲

第 9 章：南美宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第10章：中东和非洲宏基因体定序市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品类型
    • 按工作流程
    • 依技术
    • 按国家/地区
  • MEA：国家分析
    • 阿联酋宏基因组定序
    • 沙乌地阿拉伯宏基因组定序
    • 南非宏基因体定序

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 併购
  • 产品开发
  • 最近的发展

第13章：波特的分析

第 14 章：PESTEL 分析

第15章：竞争格局

  • 照明公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 赛默飞世尔科技公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 珀金埃尔默公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 凯杰公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 牛津奈米孔技术公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 加州太平洋生物科学公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 华大基因集团
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 普索马根公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 阿森塔公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments
  • 诺致基因有限公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (As Reported)
    • Recent Developments

第 16 章：策略建议17。

简介目录
Product Code: 19894

Global Metagenomics Sequencing Market has valued at USD 1.96 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 14.23% through 2028. Metagenomics sequencing is a revolutionary scientific technique that involves the analysis of genetic material collected directly from environmental samples, bypassing the need for individual organism isolation. This method provides a holistic view of the genetic diversity within microbial communities present in various habitats, including soil, water, and the human body. The process begins by extracting DNA or RNA from a mixed sample, capturing the genetic material of all microorganisms present. High-throughput sequencing technologies, such as next-generation sequencing, then generate vast amounts of genetic data from these samples. Bioinformatics tools are subsequently employed to analyze and interpret the data, revealing insights into the identities and functions of the microbial community. Metagenomics sequencing has transformed our understanding of microbial ecosystems, uncovering novel species, genes, and metabolic pathways. Its applications span diverse fields, including environmental science, agriculture, medicine, and biotechnology. The technique has been particularly impactful in studying the human microbiome, aiding in the identification of microbial contributions to health and disease. Metagenomics sequencing continues to drive discoveries, offering a powerful tool for exploring the genetic richness and functional potential of microbial communities in complex environments.

Metagenomics sequencing is a cutting-edge method that revolutionizes the study of microbial communities by directly analyzing genetic material obtained from diverse environmental samples. Unlike traditional genomics that focus on isolated organisms, metagenomics allows scientists to investigate the collective genetic information of entire microbial ecosystems. This approach is pivotal in unveiling the vast diversity and functional capabilities of microorganisms in various environments, ranging from soil and water to the human body. The process initiates with the extraction of DNA or RNA from a sample containing a mix of microorganisms. This genetic material, representing the collective genomes of the entire microbial community, is then subjected to high-throughput sequencing technologies. Next-generation sequencing platforms, for instance, generate large volumes of sequence data rapidly and cost-effectively. Bioinformatics tools are crucial in managing and interpreting this massive amount of genetic data, enabling researchers to identify the organisms present and understand their functional roles within the ecosystem. Metagenomics sequencing has transformative implications across multiple disciplines. In environmental science, it aids in understanding microbial contributions to biogeochemical cycles and ecosystem dynamics. In agriculture, it supports soil health assessments and the development of sustainable practices. In medicine, particularly in studying the human microbiome, metagenomics sequencing facilitates insights into the role of microorganisms in health and disease. Additionally, the technique has applications in biotechnology, enabling the discovery of novel enzymes and metabolic pathways with industrial relevance.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.96 Billion
Market Size 2028USD 4.33 Billion
CAGR 2023-202814.23%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

Rising Awareness and Research Initiatives

The rising awareness of the importance of metagenomics sequencing has become a significant driving force behind its global market growth. As the scientific community and industries recognize the potential of metagenomics in unraveling the mysteries of microbial communities, there is a heightened emphasis on research initiatives and collaborative efforts. Awareness campaigns, academic programs, and scientific conferences have played pivotal roles in disseminating knowledge about the applications and benefits of metagenomics sequencing. Researchers and institutions worldwide are increasingly focusing on the exploration of microbial diversity across various ecosystems, ranging from terrestrial environments to the human body. This surge in awareness has led to the initiation of extensive research projects aimed at understanding the functional roles of microorganisms and their impact on ecosystems, agriculture, medicine, and industry. The collective efforts of the scientific community in advancing metagenomics technologies and methodologies are driving innovation, with ongoing initiatives shaping the trajectory of the global metagenomics sequencing market. As a result, this heightened awareness and commitment to research contribute significantly to the market's expansion, fostering a deeper understanding of the intricate microbial world and its implications across diverse sectors.

Technological Advancements

Technological advancements stand at the forefront of propelling the global metagenomics sequencing market forward. The continuous evolution of sequencing technologies, particularly the advent of next-generation sequencing (NGS), has catalyzed a transformative shift in metagenomics. NGS platforms facilitate high-throughput sequencing, enabling the rapid and cost-effective generation of massive amounts of genetic data from complex microbial communities. These advancements not only enhance the efficiency of metagenomics sequencing but also broaden its accessibility to researchers and institutions worldwide.

The refinement of bioinformatics tools and analytical methodologies is equally pivotal in harnessing the potential of metagenomic data. Advanced computational algorithms and data processing techniques are instrumental in managing and interpreting the vast and complex datasets generated by metagenomics sequencing. These innovations not only streamline the analysis process but also improve the accuracy and depth of insights derived from metagenomic studies.

Moreover, continuous research and development efforts in the field of metagenomics technology contribute to the introduction of novel methodologies and platforms, further expanding the capabilities of metagenomics sequencing. As technology continues to progress, it not only addresses existing challenges but also unlocks new possibilities for understanding microbial ecosystems in diverse environments. In essence, technological advancements play a central role in shaping the landscape of the global metagenomics sequencing market, fostering its growth and broadening its impact across various scientific disciplines.

Increasing Prevalence of Infectious Diseases

The increasing prevalence of infectious diseases worldwide has emerged as a pivotal driver for the global metagenomics sequencing market. As the frequency and diversity of infectious agents continue to rise, there is a growing need for advanced diagnostic tools that can rapidly and comprehensively identify pathogens. Metagenomics sequencing, with its ability to analyze entire microbial communities within a sample, has proven instrumental in the detection and characterization of infectious agents. The technique allows for the identification of known pathogens as well as the discovery of novel and emerging ones, offering a comprehensive understanding of the microbial landscape. The urgency to combat infectious diseases, coupled with the limitations of traditional diagnostic methods, has fueled the adoption of metagenomics sequencing in clinical settings. This approach enables the timely and accurate diagnosis of infections, contributing to more effective treatment strategies and public health interventions. Furthermore, metagenomics sequencing facilitates the monitoring of microbial resistance patterns, aiding in the development of targeted therapies. As the global healthcare landscape grapples with infectious disease challenges, the demand for metagenomics sequencing is on the rise, positioning it as a valuable tool in the diagnostic arsenal. This trend reflects the increasing recognition of metagenomics as a critical technology in the ongoing efforts to address and mitigate the impact of infectious diseases on a global scale.

Expanding Applications in Various Industries

The global metagenomics sequencing market is experiencing a surge in demand due to the expanding applications across diverse industries. Metagenomics sequencing, with its ability to explore the genetic composition of entire microbial communities, finds relevance in agriculture, pharmaceuticals, biotechnology, and environmental monitoring. In agriculture, metagenomics contributes to soil health assessments, aiding in the development of sustainable farming practices and the identification of beneficial microbial communities for crop enhancement. In the pharmaceutical and biotechnology sectors, metagenomics sequencing plays a crucial role in drug discovery, enabling the identification of novel enzymes, bioactive compounds, and metabolic pathways from environmental samples. This has the potential to revolutionize the development of new therapeutic agents and biotechnological applications. Moreover, in environmental monitoring, metagenomics offers insights into microbial responses to changes in ecosystems, contributing to ecological conservation efforts and sustainable resource management. The versatility of metagenomics sequencing has positioned it as a valuable tool with wide-ranging implications across industries. Its application diversity reflects a growing acknowledgment of the technology's potential to drive innovation, improve processes, and address challenges in various sectors. As a result, the global metagenomics sequencing market is witnessing increased adoption as industries recognize the transformative impact of understanding and harnessing the genetic information within complex microbial communities.

Key Market Challenges

Data Complexity and Interpretation

Data complexity and interpretation pose significant challenges in the global metagenomics sequencing market. The sheer volume of data generated by high-throughput sequencing technologies, such as next-generation sequencing platforms, presents a formidable task in terms of storage, processing, and analysis. Metagenomic datasets often contain diverse genetic information from complex microbial communities, requiring sophisticated bioinformatics tools and computational resources for accurate interpretation. The complexity arises from the vast diversity of microorganisms, the dynamic nature of microbial communities, and the presence of both known and unknown species within a sample. One of the primary challenges is the development of robust analytical pipelines that can handle the intricacies of metagenomic data. Standardizing analysis methods is essential to ensure consistency and comparability across different studies. Researchers face the task of establishing reliable metrics for assessing data quality, addressing biases introduced during DNA extraction, amplification, and sequencing, and implementing effective strategies for filtering noise and artifacts. Moreover, the lack of universal standards in data reporting and interpretation adds another layer of complexity. The diverse nature of research objectives and sample types makes it challenging to establish a one-size-fits-all approach. Standardization efforts are crucial to facilitate collaboration, reproducibility, and the integration of findings from different studies. As metagenomics increasingly contributes to fields such as environmental monitoring, human health, and biotechnology, the need for user-friendly and scalable bioinformatics tools becomes more pronounced. Researchers and practitioners require solutions that can handle the intricacies of metagenomic data while providing meaningful and interpretable results. Overcoming the data complexity challenge will not only enhance the reliability of metagenomic analyses but also democratize access to these powerful tools, ensuring that a broader community of researchers can leverage metagenomics sequencing for scientific advancements and applications across diverse industries. Addressing these challenges is crucial for realizing the full potential of metagenomics in providing insights into microbial diversity, community dynamics, and functional capabilities in complex ecosystems.

Sample Contamination and Purity

Sample contamination and purity present significant challenges in the global metagenomics sequencing market, impacting the reliability and accuracy of results. Metagenomics relies on the comprehensive analysis of genetic material from microbial communities within a sample, making it susceptible to contamination from external sources. Ensuring the purity of samples is particularly critical in environmental and clinical studies where contaminants can introduce biases and distort the representation of microbial taxa. Environmental samples, such as soil or water, may be prone to contamination during collection, storage, or processing, leading to the inadvertent inclusion of extraneous genetic material. Similarly, in clinical settings, where metagenomics is applied to study the human microbiome, issues related to sample collection, handling, and processing can compromise the integrity of results. Addressing sample contamination requires rigorous quality control measures, including stringent sample collection protocols, proper storage conditions, and the implementation of contamination prevention strategies during laboratory processing. Researchers must be vigilant in minimizing the risk of introducing contaminants at every stage of the workflow, from sample collection to DNA extraction and sequencing. Additionally, the challenge extends to distinguishing between microbial DNA and host DNA, especially in human metagenomic studies. Contamination with human DNA can overshadow microbial signals, affecting the accuracy of microbiome characterization. Advanced methodologies, such as improved DNA extraction techniques and the use of negative controls, are essential to mitigate these challenges and enhance the reliability of metagenomic analyses. The global metagenomics sequencing market can benefit significantly from innovations that address sample contamination concerns. Improved protocols, quality control measures, and standardized practices will contribute to the production of more accurate and reproducible metagenomic data. Overcoming these challenges is imperative for metagenomics to maintain its integrity as a powerful tool for studying microbial communities in diverse environments and advancing our understanding of the complex relationships within ecosystems and host-associated microbiomes.

Key Market Trends

Multi-Omics Integration

The integration of multi-omics data represents a significant and evolving trend in the global metagenomics sequencing market. As the field of genomics advances, researchers increasingly recognize the value of combining metagenomics data with other omics layers, such as metatranscriptomics, metaproteomics, and metabolomics. This multi-omics integration provides a more comprehensive and nuanced understanding of microbial communities within diverse ecosystems, offering insights into both their taxonomic composition and functional dynamics. Metagenomics sequencing alone reveals the genetic makeup of microbial communities, identifying the presence of various species and their genomic potential. However, integrating this information with metatranscriptomics, which examines gene expression patterns, offers insights into the actively functioning genes within these communities. This dynamic view of gene activity helps elucidate microbial responses to environmental changes or stressors. Furthermore, the integration with metaproteomics allows researchers to study the actual proteins produced by microbial communities. This information goes beyond genetic potential, providing a direct link to functional proteins and their roles in biochemical pathways. The combination of metagenomics and metabolomics extends this understanding to the small molecules produced by microorganisms, shedding light on the metabolic interactions and potential contributions to ecosystem processes. The trend of multi-omics integration in metagenomics is particularly relevant in personalized medicine. The combination of metagenomics data with host genomics, transcriptomics, and other omics layers facilitates a holistic approach to studying the human microbiome. This has implications for understanding the role of microbial communities in health and disease, guiding the development of targeted therapies, and advancing precision medicine initiatives. As technology and analytical methods continue to evolve, the integration of multi-omics data in metagenomics studies is expected to become more refined and commonplace. This trend not only enhances the depth of insights derived from metagenomics sequencing but also reinforces its position as a powerful tool for unraveling the complexities of microbial ecosystems across various applications, from environmental monitoring to healthcare.

Applications in Personalized Medicine

Metagenomics sequencing has emerged as a pivotal tool with transformative applications in personalized medicine, representing a significant trend in the global market. The human microbiome, comprising trillions of microorganisms residing in and on the human body, plays a crucial role in maintaining health and influencing disease. Metagenomics sequencing allows for a comprehensive analysis of microbial communities associated with the human body, offering insights into the diversity, composition, and functional potential of these microbial ecosystems. In personalized medicine, metagenomics contributes to understanding the intricate relationships between the human microbiome and individual health. The technology enables the identification and characterization of specific microbial signatures associated with various health conditions, including gastrointestinal disorders, autoimmune diseases, and metabolic disorders. By studying the microbial composition of individuals, researchers and healthcare practitioners can gain valuable insights into the role of the microbiome in disease susceptibility, progression, and response to treatments. The application of metagenomics in personalized medicine extends to the development of targeted therapeutic interventions. Understanding how microbial communities influence drug metabolism, efficacy, and adverse reactions allows for the optimization of treatment strategies tailored to an individual's microbiome profile. This approach, known as precision microbiome medicine, holds the promise of enhancing therapeutic outcomes while minimizing side effects. Moreover, metagenomics sequencing is instrumental in exploring the impact of the microbiome on drug responses, immunotherapy outcomes, and the development of chronic conditions. The integration of metagenomics data with other omics layers, such as genomics and transcriptomics, further refines the understanding of the intricate interplay between host genetics and the microbiome. As the field of personalized medicine continues to advance, the role of metagenomics sequencing in unraveling the complexities of the human microbiome becomes increasingly crucial. This trend not only underscores the significance of metagenomics in healthcare but also positions it as a key player in shaping the future of personalized and precision medicine approaches.

Segmental Insights

Product & Service Insights

In 2022, the Global Metagenomics Sequencing Market was dominated by sequencing services segment and is predicted to continue expanding over the coming years. This is attributed due to their comprehensive offerings, providing end-to-end solutions. They encompass reagents, instruments, and analysis services, ensuring streamlined, expert-guided processes for researchers without the need for separate acquisitions and integrations.

Regional Insights

In 2022, the Global Metagenomics Sequencing Market was dominated by the North America segment and is predicted to continue expanding over the coming years. This is ascribed due to rising research on therapeutics proteins, and the growing healthcare infrastructure.

Key Market Players

Illumina, Inc.

Thermo Fisher Scientific, Inc.

PerkinElmer, Inc.

Novogene Co., Ltd.

Promega Corporation

QIAGEN

Takara Bio, Inc.

Oxford Nanopore Technologies

F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Metagenomics Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Metagenomics Sequencing Market, By Product & Service:

  • Reagents & Consumables
  • Instruments
  • Sequencing Services
  • Analysis & Data Interpretation Solutions

Global Metagenomics Sequencing Market, By Workflow:

  • Sample Processing & Library Preparation
  • Sequencing
  • Research and Biotechnology

Global Metagenomics Sequencing Market, By Technology:

  • 16s RNA Sequencing
  • Shotgun Metagenomic Sequencing
  • Whole-Genome Sequencing & De Novo Assembly
  • Meta-transcriptomics

Global Metagenomics Sequencing Market, By Distribution Channel:

  • Direct Sales
  • Retail Sales
  • Online Retail

Global Metagenomics Sequencing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Metagenomics Sequencing Market.

Available Customizations:

  • Global Metagenomics Sequencing Market report with the given Market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Types
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Metagenomics Sequencing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Service (Reagents & Consumables, Instruments, Sequencing Services, Analysis & Data Interpretation Solutions)
    • 5.2.2. By Workflow (Sample Processing & Library Preparation, Sequencing, Research and Biotechnology)
    • 5.2.3. By Technology (16s RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing & De Novo Assembly, Meta-transcriptomics)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product Type
    • 5.3.2. By Workflow
    • 5.3.3. By Technology
    • 5.3.4. By Region

6. North America Metagenomics Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Workflow
    • 6.2.3. By Technology
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Metagenomics Sequencing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Workflow
        • 6.3.1.2.3. By Technology
    • 6.3.2. Canada Metagenomics Sequencing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Workflow
        • 6.3.2.2.3. By Technology
    • 6.3.3. Mexico Metagenomics Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Workflow
        • 6.3.3.2.3. By Technology

7. Europe Metagenomics Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Workflow
    • 7.2.3. By Technology
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Metagenomics Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Workflow
        • 7.3.1.2.3. By Technology
    • 7.3.2. France Metagenomics Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Workflow
        • 7.3.2.2.3. By Technology
    • 7.3.3. United Kingdom Metagenomics Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Workflow
        • 7.3.3.2.3. By Technology
    • 7.3.4. Italy Metagenomics Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Workflow
        • 7.3.4.2.3. By Technology
    • 7.3.5. Spain Metagenomics Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Workflow
        • 7.3.5.2.3. By Technology

8. Asia-Pacific Metagenomics Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Workflow
    • 8.2.3. By Technology
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Metagenomics Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Workflow
        • 8.3.1.2.3. By Technology
    • 8.3.2. Japan Metagenomics Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Workflow
        • 8.3.2.2.3. By Technology
    • 8.3.3. India Metagenomics Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Workflow
        • 8.3.3.2.3. By Technology
    • 8.3.4. South Korea Metagenomics Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Workflow
        • 8.3.4.2.3. By Technology
    • 8.3.5. Australia Metagenomics Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Workflow
        • 8.3.5.2.3. By Technology

9. South America Metagenomics Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Workflow
    • 9.2.3. By Technology
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Metagenomics Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Workflow
        • 9.3.1.2.3. By Technology
    • 9.3.2. Argentina Metagenomics Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Workflow
        • 9.3.2.2.3. By Technology
    • 9.3.3. Colombia Metagenomics Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Workflow
        • 9.3.3.2.3. By Technology

10. Middle East and Africa Metagenomics Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Workflow
    • 10.2.3. By Technology
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Metagenomics Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Workflow
        • 10.3.1.2.3. By Technology
    • 10.3.2. Saudi Arabia Metagenomics Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Workflow
        • 10.3.2.2.3. By Technology
    • 10.3.3. South Africa Metagenomics Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Workflow
        • 10.3.3.2.3. By Technology

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition
  • 12.2. Product Development
  • 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

  • 15.1. Illumina Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
  • 15.2. Thermo Fisher Scientific Inc.
    • 15.2.1. Business Overview
    • 15.2.2. Company Snapshot
    • 15.2.3. Products & Services
    • 15.2.4. Financials (As Reported)
    • 15.2.5. Recent Developments
  • 15.3. Perkin Elmer Inc.
    • 15.3.1. Business Overview
    • 15.3.2. Company Snapshot
    • 15.3.3. Products & Services
    • 15.3.4. Financials (As Reported)
    • 15.3.5. Recent Developments
  • 15.4. Qiagen N.V.
    • 15.4.1. Business Overview
    • 15.4.2. Company Snapshot
    • 15.4.3. Products & Services
    • 15.4.4. Financials (As Reported)
    • 15.4.5. Recent Developments
  • 15.5. Oxford Nanopore Technologies Plc
    • 15.5.1. Business Overview
    • 15.5.2. Company Snapshot
    • 15.5.3. Products & Services
    • 15.5.4. Financials (As Reported)
    • 15.5.5. Recent Developments
  • 15.6. Pacific Biosciences of California Inc.
    • 15.6.1. Business Overview
    • 15.6.2. Company Snapshot
    • 15.6.3. Products & Services
    • 15.6.4. Financials (As Reported)
    • 15.6.5. Recent Developments
  • 15.7. BGI Group
    • 15.7.1. Business Overview
    • 15.7.2. Company Snapshot
    • 15.7.3. Products & Services
    • 15.7.4. Financials (As Reported)
    • 15.7.5. Recent Developments
  • 15.8. Psomagen, Inc.
    • 15.8.1. Business Overview
    • 15.8.2. Company Snapshot
    • 15.8.3. Products & Services
    • 15.8.4. Financials (As Reported)
    • 15.8.5. Recent Developments
  • 15.9. Azenta Inc.
    • 15.9.1. Business Overview
    • 15.9.2. Company Snapshot
    • 15.9.3. Products & Services
    • 15.9.4. Financials (As Reported)
    • 15.9.5. Recent Developments
  • 15.10. Novogene Co., Ltd.
    • 15.10.1. Business Overview
    • 15.10.2. Company Snapshot
    • 15.10.3. Products & Services
    • 15.10.4. Financials (As Reported)
    • 15.10.5. Recent Developments

16. Strategic Recommendations17.